0.83
0.83 (0%)
As of Feb 14, 2025
Seres Therapeutics, Inc. [MCRB]
Source:
Company Overview
Seres Therapeutics, Inc is a clinical-stage company focused on improving patient outcomes in medically vulnerable populations through novel live biotherapeutics.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 617 945 9626 |
| Industry | manufacturing |
| CEO | Eric D. Shaff |
| Website | www.serestherapeutics.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-121.3 |
| Net Income | $0.1 |
| Net Cash | $-96.7 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | 0.1% |
| Profit as % of Stockholder Equity | 1% |
Management Effectiveness
| Return on Equity | 1% |
| Return on Assets | 0.1% |
| Turnover Ratio | |
| EBITA | $-121.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $139.8 |
| Total Liabilities | $126 |
| Operating Cash Flow | $-148.6 |
| Investing Cash Flow | $142.3 |
| Financing Cash Flow | $-90.4 |
